538-62-5 | Sigma-Aldrich

CMRL-1066 Medium

Whitelock O. 5, 303-313. 2. Healy, G. M., and Parker, R.C. (1966). An Improved Chemically Defined Basal Medium (CMRL-1415) For Newly Explanted Mouse Embryo Cells, Journal of Cell Biology 30, 531-538. 3.

Quality Control Range Sheet- PCC-121 and PCC-221

961 pg/mL IL-2 Control 1 67 - 139 pg/mL MIP-1α Control 1 117 - 243 pg/mL Control 2 538 - 1118 pg/mL Control 2 682 -

Quality Control Ranges: MILLIPLEX® MAP Non-Human Primate Cytokine/Chemokine Kit

961 pg/mL IL-2 Control 1 67 - 139 pg/mL MIP-1α Control 1 117 - 243 pg/mL Control 2 538 - 1118 pg/mL Control 2 682 -

Quality Control Range Sheet- PCC-124 and PCC-224

mL IL-17 Control 1 70 - 145 pg/mL IL-12/23 p40 Control 1 74 - 153 pg/mL Control 2 538 - 1117 pg/mL Control 2 585 -

Quality Control Range Sheet- A6042-104 and A6042-204

3184 – 6613 pg/mL Control 2 62 – 129 pg/mL BCA-1 Control 1 18 – 37 pg/mL IFNα2 Control 1 50 – 103 pg/mL

Data Sheet - C0422

O. Vol 5, 303-313, 1957. 2. Healy, G. M., and Parker, R.C., An Improved Chemically Defined Basal Medium (CMRL-1415) For Newly Explanted Mouse Embryo Cells Journal of Cell Biology 30: 531-538, 1966.

XP725 Antibody Number-Lot Number 071M4826

26 27 28 49 50 51 52 73 74 75 76 1.2 5 6 7 8 29 30 31 32 53 54 55 56 77 78 79 80 1.3 9 10 11 12 33 34 35 36 57 58 59 60 81

Product Information Sheet - P2277

J. Biol. Chem., 252, 8415-8422 (1977). 31. Cheung, W., Biochem. Biophys. Res. Commun., 38, 533-538 (1970). 32. Bredt, D. and Snyder, S., Proc. Nat, Acad. Sci. USA, 87, 682-685 (1990). 33. Busse

Anti-NeuN, clone A60 - Data Sheet

Sigurjonsson, O., et al., PNAS (2005) 102:5227-5232. 66) Frappart, P., et al., Nature Medicine (2005) 11:538-544. 67) Peretto, P., et al., J. Comparative Neurology (2005) 487:407-427. 68) Scheffler, B., et

Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma

4 220 5 86 3 168 6 107 3 181 5 62 2 397 7 IPI00020091 a-1-acid glycoprotein 2 precursor 153 4 169 4 IPI00553177 a-1-antitrypsin precursor 354 6 81 2 559 12 336 6 481 8 527

hKv4.3/hKChIP1-CHO K1 Recombinant Cell Line

cells (numbers above red circles). 34 38 52 62 90 0 1 2 3 4

Product Information Sheet - MITOISO2

Moss, D.W., and Bates, T.E., Eur. J. Neurosci., 13(3), 529-538 (2001). 4. Salvioli, S. et al., FEBS Lett., 411(1), 77-82 (1997). 5. Lopez, M.F., et al., Electrophoresis, 21(16), 3427-3440 (

Apoptosis - Antibodies, Reagents and Kits

178 $275 siRNA plasmid, pKD-Bax-v2 H RNAi 5 µg 62-042 $349 siRNA plasmid, pKD-Bax-v3 H M R RNAi 5 µg 62-132 $349 Bax cDNA (wt) in pUSEamp TFX 5 µg 21-159 $599

Detergents Properties and Applications

09-0 1119-97-7 MW (anhydrous) 431 415 488 538 522 293 272 289 365 337 CMC** (mM) 9-15 2-6 7 3-11 1-4 14.6 7-10 7-10 1 4-5 Aggregation Number 2-3 3-12 2 4 6 2 * 62 170 80 HLB 18 16 * * *

MAPK: Antibodies, Proteins, Kits, siRNA and Reagents

M RNAi 5 µg 62-046 siRNA plasmid, pKD-MAP Kinase/Erk1-v4 H RNAi 5 µg 62-149 siRNA plasmid, pKD-MAP Kinase 1/Erk2-v5 RNAi 5 µg 62-191 siRNA plasmid, pKD-MAP Kinase/Erk1-v3 RNAi 5 µg 62-192 MAP

Cytoskeletal Signaling Antibodies, Reagents and Kits

/PKBβ-v1 H RNAi 5 µg 62-103 siRNA plasmid, pKD-Akt2/PKBβ-v6 H M RNAi 5 µg 62-119 siRNA plasmid, pKD-Akt3/PKBγ-v2 H RNAi 5 µg 62-138 siRNA plasmid, pKD-Akt3/PKBγ-v4 RNAi 5 µg 62-171 Akt3/PKBγ

XP725 Antibody List Lot 129K4831

T8300 7124 TNF P NP_000585.2 y n/d n/d 717 Topoisomerase-I T8573 7150 TOP1 M NP_003277.1 y n/d n/d 538 p53 P5813 7157 TP53 M NP_000537.3 ,NP_001119584.1 ,NP_001119585.1 , NP_001119586.1 y n/d n/d 539 p53

XP725 Antibody List Lot 129K4830

T8300 7124 TNF P NP_000585.2 y n/d n/d 717 Topoisomerase-I T8573 7150 TOP1 M NP_003277.1 y n/d n/d 538 p53 P5813 7157 TP53 M NP_000537.3 ,NP_001119584.1 ,NP_001119585.1 , NP_001119586.1 y n/d n/d 539 p53

XP725 Antibody List Lot 089K4791

T8300 7124 TNF P NP_000585.2 y n/d n/d 717 Topoisomerase-I T8573 7150 TOP1 M NP_003277.1 y n/d n/d 538 p53 P5813 7157 TP53 M NP_000537.3 ,NP_001119584.1 ,NP_001119585.1 , NP_001119586.1 y n/d n/d 539 p53

Halal Certificate

W347701 B45527 HC-23SIBR60 60. 2,3-DIETHYL-5-METHYLPYRAZINE W333603 C39750 HC-23SIKG88 61. 2,3-DIETHYLPYRAZINE W313602 C51538 HC-23SI2U52 62. 2,3-DIMETHYL-5-(2-METHYLBUTYL)PYRAZINE W530532 C42603 HC

Halal Certificate

W347701 B45527 HC-22SIAA81 60. 2,3-DIETHYL-5-METHYLPYRAZINE W333603 C39750 HC-22SIBZ10 61. 2,3-DIETHYLPYRAZINE W313602 C51538 HC-22SI4473 62. 2,3-DIMETHYL-5-(2-METHYLBUTYL)PYRAZINE W530532 C42603 HC

XP725 Worksheet for Lot Number 071M4826

FAK pTyr397 F7926 533 3 4 1 5 FAK pTyr577 F8926 534 3 4 1 6 FAK pTyr577 F8926 535 3 4 1 7 Falkor PHD1 F5303 536 3 4 1 8 Falkor PHD1 F5303 537 3 4 2 1 Fas CD95 Apo1 F4424 538 3

List of Antibodies

M0800 P n/d y y 536 p38 MAPK activated (diphosphorylated p38) M8177 M y y y 537 Negative Control NA 538 p53 P5813 M y n/d n/d 539 p53 P6874 M y n/d n/d 540 phospho-p53 (pSer392) P8982 P y y n/d 541 p53DINP1

XP725 Antibody List 013M4793

26416, 1432, 81649 Mapk14,MAPK14 NP_036081.1,NP_620583.1,NP_112282.2 M y y y 537 Negative Control NA 538 p53 P5813 7157 TP53 NP_000537.3 M y n/d n/d 539 p53 P6874 7157 TP53 NP_000537.3 M y n/d n/d 540 phospho-p53

XP725 Antibody List

26416, 1432, 81649 Mapk14,MAPK14 NP_036081.1,NP_620583.1,NP_112282.2 M y y y 537 Negative Control 538 p53 P5813 7157 TP53 NP_000537.3 M y n/d n/d 539 p53 P6874 7157 TP53 NP_000537.3 M y n/d n/d 540 phospho-p53